Stonepine reports 7.2% Femasys stake with warrants
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Femasys Inc (FEMY) has a new significant institutional holder group led by Stonepine Capital Management, LLC and related entities, which collectively report beneficial ownership of 625,000 Femasys equity-linked securities, representing 7.2% of the common stock. This position consists of 312,500 shares of common stock and warrants to acquire an additional 312,500 shares, all subject to a 9.99% beneficial ownership limitation. The ownership percentage is calculated using 8,375,027 shares of common stock outstanding as of August 13, 2026. Voting and dispositive power over the 625,000 securities is shared among Stonepine Capital Management, Stonepine Capital, L.P., Stonepine GP, LLC, and Jon M. Plexico, each of whom disclaims beneficial ownership beyond their pecuniary interest.
Key Figures
Key Terms
Schedule 13G regulatory
beneficial ownership limitation financial
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of FEMY does Stonepine Capital report owning on this Schedule 13G?
What securities tied to FEMY does Stonepine Capital hold?
What ownership percentage in FEMY do the Stonepine reporting persons disclose?
What is the beneficial ownership limitation on Stonepine’s FEMY warrants?
Who ultimately controls the FEMY position reported by Stonepine?
AI-generated analysis. How Rhea-AI works. Not financial advice.